REGN34.SA

Regeneron Pharmaceuticals, Inc. · Healthcare · Biotechnology

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$75.80B

PE Ratio

83.87

EV to Ebitda

—

Earnings Yield

1.00%

Revenue (TTM)

$3.05B

Net Income (TTM)

$903.7M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

19.00%

Profit Margin

30.00%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

0.00%

All fundamentals

Core5 fields›

Market Cap$75.80B

Revenue TTM$3.05B

Shares Outstanding6.18B

Insider Ownership0.00%

Institutional Ownership0.00%

Growth Estimates7 fields›

Revenue Growth (Quarterly YoY)19.00%

Rev Growth Est 1Y Forward0.11

EPS Growth (Quarterly YoY)-7.00%

EPS Growth Est Quarterly0

CFO Growth (Quarterly YoY)3.00%

FCF Growth (Quarterly YoY)3.00%

Dividend Growth (Quarterly YoY)-204.00%

Operations20 fields›

Revenue TTM$3.05B

Gross Margin TTM44.00%

Gross Margin (Quarterly)81.00%

Operating Margin TTM21.00%

Operating Margin (Quarterly)21.00%

Operating Expenses TTM$9.8M

Profit Margin TTM30.00%

Profit Margin (Quarterly)20.00%

Net Income TTM$903.7M

EPS TTM3.38

EPS (Quarterly)0.12

EBITDA Margin TTM29.00%

EBITDA TTM$895.5M

CFO % of Revenue TTM81.00%

CFO % of Revenue (Quarterly)30.00%

CFO TTM$2.46B

Capex % of Revenue TTM21.00%

Capital Expenditures$632.2M

FCF % of Revenue (Quarterly)25.00%

FCF TTM$774.5M

Efficiency1 fields›

ROA6.00%

Valuation12 fields›

P/E (TTM)83.87

P/E Forward16.03

PEG1.47

P/CFO30.77

P/FCF97.86

EV/Revenues (TTM)4.62

Price To Book11.81

Price to Tangible Book11.81

Earnings Yield1.00%

FCF Yield1.00%

Dividend Yield0.00%

Payout Ratio6.00%

Liquidity6 fields›

Cash Per Share81.41

Current Ratio4.13

Total Assets$8.35B

Total Liabilities$7.40B

Shareholders Equity$6.42B

Interest Expense$9.8M

Yields4 fields›

Dividend Yield0.00%

Payout Ratio6.00%

Earnings Yield1.00%

Buyback Yield-3.00%